BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/10/2017 11:54:13 PM | Browse: 993 | Download: 1885
 |
Received |
|
2017-02-07 10:48 |
|
Peer-Review Started |
|
2017-02-07 14:14 |
|
To Make the First Decision |
|
2017-03-27 11:23 |
|
Return for Revision |
|
2017-03-28 15:44 |
|
Revised |
|
2017-04-20 19:05 |
|
Second Decision |
|
2017-05-11 13:49 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2017-05-19 04:32 |
|
Articles in Press |
|
2017-05-19 04:32 |
|
Publication Fee Transferred |
|
2017-06-14 03:39 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-07-17 07:39 |
|
Publish the Manuscript Online |
|
2017-08-10 23:54 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Randomized Controlled Trial |
| Article Title |
Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Michael Davidson, Ian Chau, David Cunningham, Komel Khabra, Timothy Iveson, Tamas Hickish, Matthew Seymour and Naureen Starling |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dr. Naureen Starling, Royal Marsden Hospital NHS Foundation Trust, London and Surrey, Fulham Road, London SM25PT, United Kingdom. naureen.starling@rmh.nhs.uk |
| Key Words |
Oesophageal cancer; Adenocarcinoma; Chemotherapy; Squamous; Pooled analysis |
| Core Tip |
There is a lack of published data on differential treatment response according to histology in oesophageal cancer. This paper shows improved response rates with first-line chemotherapy and a trend towards improved survival in adenocarcinoma compared to squamous cell carcinoma (SCC). It is increasingly recognised that these histological subtypes represent discrete disease entities with divergent treatment pathways in both the early stage and advanced settings. Novel treatments in SCC remain sparse and there are few dedicated trials in this subtype. This data highlights the poor outcomes seen with chemotherapy alone and the need for further research, particularly for SCC. |
| Publish Date |
2017-08-10 23:54 |
| Citation |
Davidson M, Chau I, Cunningham D, Khabra K, Iveson T, Hickish T, Seymour M, Starling N. Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancer. World J Gastrointest Oncol 2017; 9(8): 333-340 |
| URL |
http://www.wjgnet.com/1948-5204/full/v9/i8/333.htm |
| DOI |
http://dx.doi.org/10.4251/wjgo.v9.i8.333 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
